(4) Consistent with human NASH, CCR9 was also expressed on HSCs in NASH mice and CCR9-deficient HSCs show fewer fibrogenic phenotypes. The gene discussed is CCR9; the disease is metabolic dysfunction-associated steatohepatitis.